SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY)
TRIB 0.826-0.5%Nov 20 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Peter Caradonna who wrote (692)5/8/1996 1:16:00 AM
From: jay silberman   of 14328
 
Peter,

With respect to the size of the market, here's a post from misc.invest.stocks:

Subject: Trinity Biotech (TRIBY) Buying Opportunity
Date: Tue, 07 May 1996 12:27:42 -0700
From: HJ <howard37@pixi.com>
Organization: Pacific Information eXchange, Inc.
Newsgroups: misc.invest.stocks

This red hot stock finally took a breather today.

I'm glad that the hype died down on this great stock.

By the way, the Dick Davis Digest noted TRIBY as one of it's top picks
for '96 way back in December; the newsletter gave a three year target
of $25 for the stock.

Something to think about while you are holding TRIBY:

When you look at the 50 billion dollar diagnostics industry, if TRIBY
can even capture 1% of that market, it's a 500 million dollar company.
That would be a 50x increase in revenues. I imagine that with a
net margin of 10% (lower than historical), we would be talking about 50
million dollars in profit, or $3.50-$4.00 a share in net.

The stock would then be trading at $70 (PE=20) to $140 (PE=40).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News